The mutant-activated KRAS promotes tumor proliferation, metastasis, and invasion by stimulating multiple signaling routing pathways, such as the RAF-MEK-ERK signaling pathway [11], PI3K-AKT signaling pathway [12,13], and other signaling pathways [12,14]. The gene discussed is PIK3CA; the disease is neoplasm.